The role of procalcitonin in early differential diagnosis of suspected children with COVID-19

Introduction

Children are naturally susceptible to various respiratory viruses due to their imperfect immune systems. Since the outbreak of coronavirus disease 2019 (COVID-19) began in Wuhan city, Hubei province, China [1,2], more than 2,000 pediatric cases have been reported nationwide in just over two months [3]. Limited by accuracy of nucleic acid detection [4], relative reagent shortage and non-specificity of imaging findings, early differential diagnosis of suspected pediatric patients is difficult to some extent. Obviously, this has a serious impact on timely triage and the following reasonable treatment.

At present, a growing number of studies have focused on diagnosis and treatment of confirmed cases, but few data are available on clinical characteristics and early identification of suspected pediatric patients with COVID-19 as a special population. As a traditional biomarker, procalcitonin (PCT) have shown superior value in differentiating bacterial and viral infections as well as bacterial coinfections. However, the role of PCT in identifying between viruses and viruses or viral coinfection remain unknown. We aimed to identify the clinical features of COVID-19 in children and evaluate the role of PCT in early differential diagnosis, so as to provide a basis for the follow-up timely and reasonable treatment and effective implementation of prevention and control measures.

Materials and Methods

Results

From Jan 22nd to Mar 1st, a total of 77 suspected pediatric patients were admitted, and 39 (50.6%) were confirmed with COVID-19, including 3 (3.9%) cases of RSV coinfection, and 1 (1.3%) case with INF B coinfection.5 (6.5%) of 38 (49.4%) cases of non-COVID-19 were excluded by laboratory results and CT scan, consisting of 3 (3.9%) cases with PCT greater than 0.5 ng/mL, were considered as bacterial infection, and 2 (2.6%) cases were considered as MP coinfection (Supplement Table 1). The including 33 (42.9%) patients consisted of 3 (3.9%) cases of INF A, 2 (2.6%) cases of INF B, 9 (11.7%) cases of RSV and 19 (18.2%) cases of unidentified non-bacterial pathogens.

Compared with non-COVID-19 group (n=33), COVID-19 confirmed group (n=39) had fewer fever(OR[95% CI]0.467[0.314-0.694]; P=.000) and symptoms of ARI (0.533[0.36-0.788]; P=.001), more asymptomatic (13.568[1.895-96.729]; P=000), and more family cluster infections (5.077 [2.224-11.591]; P=.000), while chest CT had more positive findings of viral pneumonia (1.822[1.143-2.906]; P=.008). Age (6.9[3.6-10.5] vs 5[2.1-7.6]; P=.088) and gender (43.6% vs 57.6%; P=344) were statistically insignificant (Table 1). Among all of 4 coinfection cases, 4 had fever and symptoms of ARI, 3 had positive CT findings and 1 was family cluster infection (Supplement Table 1). Compared with non-COVID-19 (n=33) and coinfection (n=4) group, COVID-19 alone (n=35) group had significant statistical differences in PCT (0.05 [0.029-0.076] vs 0.103[0.053-0.21] and 0.144[0.109-2.26]; P=000, P=010), percentage of neutrophil (N%) (40.9[30-48.5] vs 54.8[41.4-67.5]; P=.003), percentage of lymphocyte (L%) (45.3[39.2-56.6] vs 33.2[22.7-42.5]; P=.003), neutrophil count (NC) (2.25[1.43-3.53] vs 3.33[2.8-5.18]; P=.014), lymphocyte count (LC) (2.68[1.99-4.01] vs 2.26 [1.67-2.92]; P=.043), high sensitivity C-reactive protein (hs-CRP) (5.5[1.1-9] vs 9.1 [7.4-9.5]; P=.007). while white blood cell (WBC) count, hemoglobin (Hb) and platelet (PLT) were statistically insignificant (Table 2).

We grouped coinfections and non-COVID-19 infections into one category, and used binary logistic regression analysis to screen independent differential diagnostic indicators for COVID-19 alone infections. WBC, N%, L%, NC, LC, hs-CRP and PCT were entered into a backward stepwise multivariate logistic regression model, and the last step was to obtain two independent indicators of NC (P=0.082) and PCT (P=0.000) (Table 3). Goodness of fit testing (Hosmer-Lemeshow test) was used to assess deviations between observed and expected values. A P value of >.05 implies no significant difference between the observed and expected values. The P value of the goodness-of-fit testing of our model is 0.803, and therefore it is acceptable (Figure 1). Analysis of the AUC of the ROC curve was constructed to assess the differentiating performance. The AUC of overall model is 0.834 ([95% CI][0.741-0.926]; P=.000). PCT as a differential diagnostic indicator of COVID-19 alone, the AUC is 0.809 ([0.710-0.909]; P=. 000) (Figure 1,Table 4). Considering the principle of practicability and good accuracy, the PCT cut-off value is optimized and adjusted to 0.1ng/mL, the sensitivity, specificity, PPV, and NPV of differentiating are 65.9%, 78.6%, 82.9%, and 59.2% (Table 5).

• Download figure
• Open in new tab

Figure 1.

The P value of Hosmer-Lemeshow testing of overall model is 0.803. The AUC for model and PCT were 0.834 and 0.809, respectively.

Discussion

Every winter and spring, a variety of virus infections are prevalent worldwide, such as parainfluenza, RSV, INF A and B, rhinovirus and cytomegalovirus, etc [8,9]. A significant number of community acquired pneumonia (CAP) are caused by viruses, either directly or as part of a coinfection. The clinical picture of these different pneumonias can be very similar, but viral infection is more common in the pediatric populations. Despite great advances in virus detection and pneumonia imaging [4], the identification and differential diagnosis of viral infections has been facing enormous challenges because laboratory detections and radiographic images are not always in agreement with clinical features [10,11]. RT-PCR methods based on spike gene and N gene were widely used for detecting nucleic acid, and were considered a gold standard for COVID-19 confirmed [12-14]. However, this method had its limitations, such as false positive or false negative results, time consuming, false sampling, inconsistence of sample collections and preparations. Most importantly, the inaccuracy of RT-PCR method caused problems in timely triage, isolating the source of infection, the following reasonable treatment, early removal of isolation, and improvement of psychological stress in children. In addition, CT changes in novel coronaviral pneumonia are nonspecific and difficult to differentiate from other viral infections [6,11]. Therefore, it is necessary to start from other clinical features and laboratory data, independent of nucleic acid detection and chest CT, to provide a basis for early differential diagnosis.

As a viral infection, it is obvious that children are especially susceptible to COVID-19. Most of the infected children we observed are asymptomatic or mildly febrile and or symptoms of ARI [3,15]. However, the changes of chest CT are very typical of viral pneumonia [11], which is consistent with the results of other relevant reports. Also, from the COVID-19 cases with coinfection, they all had fever and symptoms of ARI, chest CT findings of viral pneumonia were also typical. Therefore, COVID-19 with other viral coinfections may be more common in children [6]. Pediatric patients should be alert to the possibility of coinfection if severe symptoms appear. Compared with other non-bacterial pathogens, COVID-19 has more family cluster infections, which indicates that the virus is more infectious and has the ability of sustained human-to-human transmission. When developing preventive and control measures for children, disinfecting droplets and household environment and hand hygiene may be the top priorities [16].

For the last two decades, most of studies have been carried out by using, alone or in combination, WBC count, and serum hs-CRP and PCT concentration [17,18]. PCT appears to be most effective in selecting bacterial cases and assessing severity. However, the precise cut-offs between the separation of bacteria from viruses and the separation between mild and severe separations have not been established [19]. In adults, the normal reference value of PCT is less than 0.1 ng/mL. Between 0.1 and 0.25 ng/mL represents a viral infection. Between 0.25 and 0.5 ng/mL, bacterial or bacterial coinfection is less likely to require antibiotic treatment. Data regarding children, despite being limited, are consistent with those collected in adults. Li Z et al found that serum PCT level could provide a useful method of distinguishing bacterial coinfections from an H1N1 influenza infection alone in children during the early disease phase[20]. Chen ZM et al also suggested using a PCT>0.5 ng/mL to identify COVID-19 with bacterial coinfections [7].

Our investigation also used the criterion of PCT>0.5 ng/mL to exclude bacterial infection or coinfection. Three cases in the non-COVID-19 group considered bacterial infections, and one case in the COVID-19 confirmed group had IFN B coinfection, but the possibility of combined bacterial coinfection cannot be ruled out. Interestingly, the PCT of the other three cases with RSV coinfection in the COVID-19 confirmed group was still significantly higher than that of COVID-19 alone. Limited to laboratory testing methods and personnel during the epidemic, except for COVID-19, our hospital can only perform RT-PCR detection of IFN A, B, RSV and cytomegalovirus. Unidentified nonbacterial infections may be other types of viral infections. It also does not rule out that some 2019-nCoV infections may have these other viral coinfection.

There are several limitations in our retrospective cohort study. First, due to the small sample size of the single-center research hospital, in particular, there were only 4 cases in the coinfection group, which may have certain sampling errors. Second, the children may be in different stages of disease when they are admitted to the hospital. Therefore, these results should be carefully interpreted owing to potential selection bias and residual confounding. Larger cohort studies from other cities in China and other countries may also be needed to provide further data support.

Conclusions

Asymptoms or mild symptoms, positive CT findings and family cluster infection are the main clinical features of COVID-19 in children. With good performance, PCT can provide an important basis for differentiating COVID-19 alone and other viral infection or viral coinfection.